We compared magnetic resonance imaging (MRI), magnetic resonance angiography, and transcranial Doppler ultrasonography as predictors of specific neurocognitive functions in children with sickle cell disease. Participants were 27 children with sickle cell anemia (hemoglobin SS) who were participants in the Stroke Prevention Trial in Sickle Cell Anemia (STOP) and had no documented history of stroke. Children's MRIs were classified as normal or silent infarct, and their magnetic resonance angiograms were classified as normal or abnormal. The highest time-averaged mean flow velocity on transcranial Doppler ultrasonographic examination of the major cerebral arteries was analyzed. Age and hematocrit also were analyzed as predictor variables. The battery of neurocognitive tests included measures of intellectual functioning, academic achievement, attention, memory, visual-motor integration, and executive functions. MRI, magnetic resonance angiography, transcranial Doppler ultrasonography, age, and hematocrit were analyzed as predictors of participants' performance on the various measures of neurocognitive functioning. Age and hematocrit were robust predictors of a number of global and specific neurocognitive functions. When age and hematocrit were controlled, transcranial Doppler ultrasonography was a significantly unique predictor of verbal memory. We found an association between low hemoglobin and neurocognitive impairment. We also found that abnormalities on transcranial Doppler ultrasonography can herald subtle neurocognitive deficits. (J Child Neurol 2006;21:37—44).
Get full access to this article
View all access options for this article.
References
1.
Charache S., Lubin B., Reid CD: Management and Therapy of Sickle Cell Disease. (NIH Publication No. 89-2117). Washington, DC, National Institutes of Health, 1989.
2.
Consensus Conference: Newborn screening for sickle cell disease and other hemoglobinopathies. JAMA1987;258:1205—1209.
3.
Moser FG, Miller ST, Bello JA, et al: The spectrum of brain MR abnormalities in sickle cell disease: A report from the Cooperative Study of Sickle Cell Disease. AJNR Am J Neuroradiol1996;17:965—972.
4.
Ohene-Frempong K., Weiner SJ, Sleeper LA, et al: Strokes in sickle cell disease: Rates and risk factors. Blood1998;91:288—294.
5.
Pavlakis SG, Bello J., Prohovnik I., et al: Brain infarction in sickle cell anemia: Magnetic resonance imaging correlates. Ann Neurol1988;23:125—130.
Rothman SM, Fulling KH, Nelson JS: Sickle cell anemia and central nervous system infarction: A neuropathological study. Ann Neurol1986;20:684—690.
8.
Russell MO, Goldberg HI, Reis L., et al: Transfusion therapy for cerebrovascular abnormalities in sickle cell disease. J Pediatr1976;88:382—387.
9.
Stockman JA, Nigro MA, Mishkin MM, Oski FA: Occlusion of large cerebral vessels in sickle cell anemia. N Engl J Med1972;287:846—849.
10.
Pavlakis SG , Prohovnik I., Piomelli S., DeVivo DC: Neurologic complications of sickle cell disease . Adv Pediatr1989;36:247—276.
11.
El Gammal JE , Adams RJ, Nichols FT, et al: MR and CT investigation of cerebrovascular disease in sickle cell patients. AJNR Am J Neuroradiol1986; 7: 1043—1049.
12.
Glauser TA, Siegal MJ, Lee Bcp, DeBaun MR: Accuracy of neurologic examination and history in detecting evidence of MRIdiagnosed cerebral infarctions in children with sickle cell hemoglobinopathy. J Child Neurol1995;10:88—92.
13.
Kuglar S., Anderson B., Cross D., et al: Abnormal cranial magnetic resonance imaging scans in sickle cell disease: Neurological correlates and clinical implications. Arch Neurol1993; 50: 629—635.
14.
Adams R., McKie V., Nichols F. et al: The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med1992;326:605—610.
15.
Adams RJ, McKie VC, Hsu L., et al: Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med1998;339:5—100.
16.
Kandeel AY, Zimmerman RA, Ohene-Frempong K: Comparison of magnetic resonance angiography and conventional angiography in sickle cell disease. Neuroradiology1996;38:409—416.
17.
Adams RJ, Ohene-Frempong K., Wang W.: Sickle cell and the brain. Hematology2001 ;31—46.
18.
Seibert JJ, Glasier CM, Kirby RS, et al: Transcranial Doppler, MRA, and MRI as a screening examination for cerebrovascular disease in patients with sickle cell anemia. Pediatr Radiol1998;28:138—142.
19.
Kogutt MS, Goldway SS, Gupta K., et al: Correlation of transcranial Doppler ultrasonography with MRI and MRA in the evaluation of sickle cell disease patients with prior stroke . Pediatr Radiol1994;24:204—206.
20.
Seibert JJ, Miller SF, Kirby RS, et al: Cerebrovascular disease in symptomatic and asymptomatic patients with sickle cell anemia: Screening with duplex transcranial Doppler US—Correlation with MR imaging and MR angiography. Neuroradiology1993;189:457—466.
21.
Siegel MJ, Luker GD, Glauser JA, DeBaun MR: Cerebral infarction in sickle cell disease: Transcranial Doppler US versus neurologic examination. Radiology1995;197:191—194.
22.
Verlhac S., Bernaudin F., Tortrat D., et al: Detection of cerebrovascular disease in patients with sickle cell disease using transcranial Doppler sonography: Correlation with MRI, MRA, and conventional angiography. Pediatr Radiol1995; 25: 514—519.
23.
Wang WC, Gallagher DM, Pegelow CH, et al: Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease. J Pediatr Hematol Oncol2000;22:335—339.
24.
Armstrong FD , Thompson RJ, Wang W., et al: Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Pediatrics1996;97:864—870.
25.
Craft S., Schatz J., Glauser TA, et al: Neuropsychologic effects of stroke in children with sickle cell anemia. J Pediatr1993;123: 712—717.
26.
Boni LA, Brown RT, Davis PC, et al: Social information processing and magnetic resonance imaging in children with sickle cell disease. J Pediatr Psychol2001;26:309—319.
27.
Cohen MJ, Branch WB, McKie VC, Adams RJ: Neuropsychological impairment in children with sickle cell anemia and strokes . Clin Pediatr1994;33:517—524.
28.
Craft S., Schatz J., Glauser T., et al: The effects of bifrontal stroke during childhood on visual attention: Evidence from children with sickle cell anemia. Dev Neuropsychol1994;10:285—297.
29.
Schatz J., Craft S., Koby M., et al: Neuropsychological deficits in children with sickle cell disease and cerebral infarction: Role of lesion site and location. Child Neuropsychol1999;5:92—103.
30.
Brown RT, Davis PC, Lambert R., et al: Neurocognitive functioning and magnetic resonance imaging in children with sickle cell disease. J Pediatr Psychol2000;25:503—513.
31.
DeBaun MR, Schatz J., Siegel MJ, et al: Cognitive screening examinations for patients with sickle cell disease: Regional alterations. Arch Neurol1998;45:78—82.
32.
Steen RG, Xiong X., Mulhern RK, et al: Subtle abnormalities in children with sickle cell disease: Relationship to blood hematocrit. Ann Neurol1999;45:279—286.
33.
Watkins KE, Hewes Dkm, Connelly A., et al: Cognitive deficits associated with frontal lobe infarction in children with sickle cell disease. Dev Med Child Neurol1998;40:536—543.
34.
Bernaudin F. , Verlhac S., Freard F., et al: Multicenter prospective study of children with sickle cell disease: Radiographic and psychometric correlation. J Child Neurol2000;15:333—343.
35.
Kral MC, Brown RT, Nietert PJ, et al: Transcranial Doppler ultrasonography and neurocognitive functioning in children with sickle cell disease. Pediatrics2003;112:324—331.
36.
Schatz J., Finke RL, Kellett JM, Kramer JH: Cognitive functioning in children with sickle cell disease: A meta-analysis . J Pediatr Psychol2002;27:739—748.
37.
Adams RJ, McKie VC, Brambilla D., et al: Stroke Prevention Trial in Sickle Cell Anemia. Control Clin Trials1997;1:110—129.
38.
Kral MC, Brown RT, Hynd GW: Neuropsychological aspects of pediatric sickle cell disease. Neuropsychol Rev2001;11:179—196.
39.
Wechsler D.: Weschler Abbreviated Scale of Intelligence. San Antonio, TX, The Psychological Corporation, 1999.
Conners CK: Conners' Continuous Performance Test, 2nd ed. North Tonawanda, NY, MultiHealth Systems , 1995.
45.
Cohen MJ: Children's Memory Scale. San Antonio, TX, The Psychological Corporation, 1997.
46.
Beery KE: The Developmental Test of Visual-Motor Integration, 4th ed. Parsippany, NJ, Modern Curriculum Press, 1997.
47.
Riccio CA, Cohen MJ, Hall J., Ross CM: The third and fourth factors of the WISC-III: What they don't measure. J Psychol Assmt1997;15:27—39.
48.
Reitan RM, Wolfson D.: The Halsted-Reitan Neuropsychological Test Battery. Tucson, AZ, Neuropsychology Press, 1985.
49.
Balkaran B. , Char G., Morris JS, et al: Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr1992;120:360—366.
50.
Early CJ, Kittner SJ, Feeser BR, et al: Stroke in children and sickle cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology1998;51:169—176.
51.
Brown RT, Buchanan I., Doepke K., et al: Cognitive and academic functioning in children with sickle cell disease. J Learn Disabil1993;26:33—45.
